Disposable Colonoscope Assists Colorectal Cancer Screening
|
By HospiMedica International staff writers Posted on 14 Dec 2014 |

Image: The Aer-O-Scope Colonoscope System (Photo courtesy of GI View).
An advanced, single use, self-propelled colonoscope offers omnidirectional colorectal cancer (CC) screening.
The Aer-O-Scope System consists of two primary components. The first is the scanning colonoscope component, with a novel optical system that maximizes visualization of the entire colonic mucosa, including behind haustral folds, thanks to advanced optics that enable 360° panoramic visualization, as well as a front view similar to that of conventional colonoscopy. A soft multilumen tube and pneumatic mechanism, directed by pressure measurement control software, makes use of balloons and low pressure CO2 to provide self-propelled intubation and advancement within the colon.
The second component is the Aer-O-Scope work station, which provides the elements to operate the disposable scanner. These include CO2, water, suction and air pressure, and the power supply for the camera and illumination. The work station also receives and processes transmitted data from the camera and scanner. The work station physician interface is equipped with an ergonomic joystick for intuitive control of navigation, insufflation, irrigation, and suction. The Aer-O-Scope Colonoscope System is a product of GI View (Ramat Gan, Israel), and has been approved by the US Food and Drug Administration (FDA).
“Aer-O-Scope is the only colorectal screening product that is single use, self-propelled and has 360° omnidirectional visualization,” said Tal Simchony, MD, CEO of GI-View. “This enables the physician to observe all the mucosa of the colon, including behind folds, which is critical for a complete colonic assessment. If a polyp is there, Aer-O-Scope will allow the physician the best possible chance of finding it.”
Colonoscopy involves the endoscopic examination of the entire large bowel and the distal part of the small bowel via the anus, and has become a primary routine screening test for CC in people who are over 50 years of age. Among people who have had an initial colonoscopy that found no polyps, the risk of developing CC within five years is extremely low, and there is therefore no need for those people to have another colonoscopy sooner than five years after the first screening.
Related Links:
GI View
The Aer-O-Scope System consists of two primary components. The first is the scanning colonoscope component, with a novel optical system that maximizes visualization of the entire colonic mucosa, including behind haustral folds, thanks to advanced optics that enable 360° panoramic visualization, as well as a front view similar to that of conventional colonoscopy. A soft multilumen tube and pneumatic mechanism, directed by pressure measurement control software, makes use of balloons and low pressure CO2 to provide self-propelled intubation and advancement within the colon.
The second component is the Aer-O-Scope work station, which provides the elements to operate the disposable scanner. These include CO2, water, suction and air pressure, and the power supply for the camera and illumination. The work station also receives and processes transmitted data from the camera and scanner. The work station physician interface is equipped with an ergonomic joystick for intuitive control of navigation, insufflation, irrigation, and suction. The Aer-O-Scope Colonoscope System is a product of GI View (Ramat Gan, Israel), and has been approved by the US Food and Drug Administration (FDA).
“Aer-O-Scope is the only colorectal screening product that is single use, self-propelled and has 360° omnidirectional visualization,” said Tal Simchony, MD, CEO of GI-View. “This enables the physician to observe all the mucosa of the colon, including behind folds, which is critical for a complete colonic assessment. If a polyp is there, Aer-O-Scope will allow the physician the best possible chance of finding it.”
Colonoscopy involves the endoscopic examination of the entire large bowel and the distal part of the small bowel via the anus, and has become a primary routine screening test for CC in people who are over 50 years of age. Among people who have had an initial colonoscopy that found no polyps, the risk of developing CC within five years is extremely low, and there is therefore no need for those people to have another colonoscopy sooner than five years after the first screening.
Related Links:
GI View
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







